DE60025342D1 - Komplex aus n-glykolisierten proteinen (siblings) und faktor h - Google Patents

Komplex aus n-glykolisierten proteinen (siblings) und faktor h

Info

Publication number
DE60025342D1
DE60025342D1 DE60025342T DE60025342T DE60025342D1 DE 60025342 D1 DE60025342 D1 DE 60025342D1 DE 60025342 T DE60025342 T DE 60025342T DE 60025342 T DE60025342 T DE 60025342T DE 60025342 D1 DE60025342 D1 DE 60025342D1
Authority
DE
Germany
Prior art keywords
siblings
proteins
factor
provides methods
glycolised
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60025342T
Other languages
English (en)
Inventor
W Fisher
S Fedarko
F Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22435520&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60025342(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of DE60025342D1 publication Critical patent/DE60025342D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/108—Osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60025342T 1999-04-09 2000-04-07 Komplex aus n-glykolisierten proteinen (siblings) und faktor h Expired - Lifetime DE60025342D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12846899P 1999-04-09 1999-04-09
PCT/US2000/009349 WO2000062065A1 (en) 1999-04-09 2000-04-07 Complex formed by n-linked glycoproteins (siblings) and factor h

Publications (1)

Publication Number Publication Date
DE60025342D1 true DE60025342D1 (de) 2006-03-30

Family

ID=22435520

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60025342T Expired - Lifetime DE60025342D1 (de) 1999-04-09 2000-04-07 Komplex aus n-glykolisierten proteinen (siblings) und faktor h

Country Status (6)

Country Link
EP (1) EP1169642B1 (de)
AT (1) ATE315229T1 (de)
AU (1) AU769185B2 (de)
CA (1) CA2370018A1 (de)
DE (1) DE60025342D1 (de)
WO (1) WO2000062065A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1399186T3 (da) 2001-06-13 2010-03-29 Armbruster Biotechnology Gmbh Lægemiddel til behandling af tumorer og disses metastaser under anvendelse af et bindemolekyle mod knogle-sialoprotein
DE50213368D1 (de) 2001-06-13 2009-04-30 Immundiagnostik Ag Bestimmung von bone-sialoprotein in körperflüssigkeiten für onkologische fragestellungen
WO2004013311A2 (en) 2002-08-06 2004-02-12 Diadexus, Inc. Compositions and methods relating to ovarian specific genes and proteins
DE502006004924D1 (de) 2005-05-31 2009-11-05 Ralf Jochem Therapeutsche zusammensetzung zur vorbeugung und bekämpfung von knochenmetastasen
ES2672806T3 (es) 2009-07-03 2018-06-18 Armbruster Biotechnology Gmbh Injerto óseo y material biocompuesto

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340934A (en) * 1989-11-03 1994-08-23 The United States Of Americas As Represented By The Secretary Of Health & Human Services CDNA sequences of human bone matrix proteins
JPH09138213A (ja) * 1995-11-15 1997-05-27 Sangi Co Ltd 免疫センサ
JP5226308B2 (ja) * 2004-07-26 2013-07-03 ジェネンテック， インコーポレイテッド 肝細胞増殖因子活性化を制御するための方法及び組成物

Also Published As

Publication number Publication date
AU4334100A (en) 2000-11-14
WO2000062065B1 (en) 2001-01-25
ATE315229T1 (de) 2006-02-15
WO2000062065A1 (en) 2000-10-19
CA2370018A1 (en) 2000-10-19
EP1169642B1 (de) 2006-01-04
AU769185B2 (en) 2004-01-15
EP1169642A1 (de) 2002-01-09

Similar Documents

Publication Publication Date Title
WO2001036470A3 (en) Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides
TR200101482T2 (tr) WT1'e özgü imünoterapi için bileşimler
AU4073297A (en) Methods and compositions for the detection of cervical cancer
ATE454468T1 (de) Nachweis der instabilität von mikrosatelliten und verwendung davon bei der tumordiagnose
ATE451390T1 (de) Polypeptide zur bindung an das b-lymphozyten- stimulatorische protein (blys)
TR200200763T2 (tr) Antiviral bileşimler
TR200000115T2 (tr) Tüberkülozun immünoterapi ve teşhisi için bileşikler ve bu bileşiklerin kullanımı için yöntemler.
ATE481645T1 (de) Biomarker für den frühzeitigen nachweis von ovarialkarzinom
WO2005113838A3 (en) Detection of protein translocation by beta-galactosidase reporter fragment complementation
WO2005019470A3 (en) Detecting and profiling molecular complexes
WO1999045098A3 (en) Delivery or proteins into eukaryotic cells with recombinant yersinia
WO2002001230A3 (en) Rapid and sensitive detection of protein aggregation
WO2002063271A3 (en) Activity based probe analysis
JP2010528584A5 (de)
WO2001025791A3 (en) Prostate cancer marker proteins
DE60025342D1 (de) Komplex aus n-glykolisierten proteinen (siblings) und faktor h
Yano et al. SYT–SSX fusion genes in synovial sarcoma of the thorax
ATE406094T1 (de) Identifizierung und charakterisierung von genen
MXPA05011085A (es) Composiciones y metodos relacionados a stop-1.
WO2004074325A3 (en) Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers
WO2004083241A3 (en) Btc-interacting proteins and use thereof
WO2006063009A3 (en) Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on proteins differentially expressed in serum
ATE399176T1 (de) Nonapeptidische ny-eso-1 derivate und deren verwendung
WO2002078636A3 (en) Detection and treatment of colorectal cancer
WO2002075314A3 (en) Detection and treatment of prostate cancer

Legal Events

Date Code Title Description
8332 No legal effect for de